U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07521618) titled 'One-stop Diagnosis and Treatment for Suspected Lung Cancer: Combined RBS, nClE, OBCT and Ablation' on March 31.
Brief Summary: Using RBS as the navigation and treatment platform, precisely navigate to the target lesion. Utilize r-EUBS and nCLE to identify the lesion, and when the confocal AI model recognizes the lesion as malignant, perform a biopsy. Subsequently, under the guidance of OBCT, carry out ablation treatment of the lesion.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Lung Cancer (Suspected or Confirmed)
Cryoablation
Robotic Bronchoscopy System
Confocal Laser Endomicroscopy
Intervention:
PROCEDU...